NET1 Activators
The chemicals listed above are primarily inhibitors or modulators of various signaling pathways that can indirectly influence the activity of NET1, a RhoA-specific guanine nucleotide exchange factor involved in the organization of the actin cytoskeleton and cellular transformation. Direct chemical activators specific to NET1 are not well-established, but these compounds can impact NET1 activity by modulating related cellular processes. Phorbol 12-myristate 13-acetate (PMA) and Forskolin exemplify the indirect modulation of NET1 through pathways like Protein Kinase C (PKC) and adenylate cyclase, respectively. These pathways are crucial in regulating cytoskeletal dynamics, where NET1 plays a significant role. Compounds like Y-27632 and Blebbistatin, which target Rho-associated kinase (ROCK) and myosin II, respectively, highlight the interconnection between NET1's function and the broader Rho GTPase-regulated cytoskeletal organization.
Inhibitors of kinases and phosphatases, such as Staurosporine, LY294002 (PI3K inhibitor), U0126 (MEK inhibitor), SB203580 (p38 MAPK inhibitor), and PD98059 (MEK inhibitor), demonstrate the complex network of signaling pathways that can indirectly influence NET1 activity. These inhibitors affect various aspects of cell signaling, including growth, differentiation, and migration, which are processes where NET1 is potentially involved. Cytosine β-D-arabinofuranoside and Wortmannin, targeting DNA synthesis and PI3K activity, respectively, further illustrate the diverse mechanisms through which NET1 activity can be influenced.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, an activator of Protein Kinase C (PKC), can indirectly influence NET1 activity by modulating signaling pathways involved in cytoskeletal rearrangements. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, by increasing intracellular cAMP levels, can impact signaling pathways that may indirectly modulate NET1 activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632, a ROCK inhibitor, can indirectly influence NET1 activity by altering RhoA-mediated signaling, which is closely related to NET1's function. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, a potent kinase inhibitor, can indirectly affect NET1 activity through its broad action on various kinases involved in cell signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, can affect various signaling pathways, potentially influencing NET1's role in the cytoskeletal organization. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, might indirectly impact NET1's function in cellular processes influenced by the p38 MAPK pathway. | ||||||
1-β-D-Arabinofuranosylcytosine | 147-94-4 | sc-201628 sc-201628A sc-201628B sc-201628C sc-201628D | 1 g 5 g 25 g 100 g 250 g | $150.00 $263.00 $518.00 $731.00 $1461.00 | 1 | |
This compound, affecting DNA synthesis, could indirectly influence NET1 activity as part of broader changes in cellular behavior. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, an inhibitor of MEK, might modulate NET1 activity indirectly through the MAPK/ERK pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, could indirectly influence NET1's role in signaling pathways controlled by PI3K activity. | ||||||